PIK3CD and acute myeloid leukemia: Either used alone or in combination with other drugs, PI3K/Akt/mTOR signaling inhibitors have been proven useful for down-regulating cell proliferation and inducing apoptosis in pre-clinical settings of AML, using cell lines or animal models.